Guy P Nohra insider trades: Bioventus (BVS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Guy reports to the SEC
and 16 more companies
Open-market buys and sales
35 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | BVS | ↓ Sell | 10,000 | $7.57 | $76K | Direct | Dec 8, 2025 (4d) |
| Mar 4, 2021 | ALLK | ↓ Sell | 25,768 | $111.64 | $2.9M | Direct | Mar 8, 2021 (4d) |
| Jun 17, 2020 | ALLK | ↓ Sell | 7,692 | $75.62 | $582K | Direct | Jun 19, 2020 (2d) |
| Jul 23, 2018 | ALLK | ↑ Buy | 250,000 | $18.00 | $4.5M | Indirect | Jul 23, 2018 (0d) |
| Dec 30, 2015 | NEOT | ↓ Sell | 797,987 | $1.51 | $1.2M | Direct | Dec 30, 2015 (0d) |
| Dec 15, 2015 | NEOT | ↓ Sell | 529,261 | $1.44 | $762K | Direct | Dec 17, 2015 (2d) |
| Jun 8, 2015 | ZSPH | ↓ Sell | 175,427 | $57.86 | $10.1M | Direct | Jun 9, 2015 (1d) |
| Jun 4, 2015 | ZSPH | ↓ Sell | 111,597 | $57.30 | $6.4M | Direct | Jun 5, 2015 (1d) |
| Jun 2, 2015 | ZSPH | ↓ Sell | 296,423 | $58.00 | $17.2M | Direct | Jun 2, 2015 (0d) |
| Apr 14, 2015 | CBYL | ↑ Buy | 877,500 | $5.00 | $4.4M | Indirect | Apr 14, 2015 (0d) |
| Dec 10, 2014 | TRVN | ↑ Buy | 500,000 | $4.00 | $2.0M | Indirect | Dec 10, 2014 (0d) |
| Nov 25, 2014 | NEOT | ↓ Sell | 149,286 | $14.00 | $2.1M | Alta Partners VIII, LP | Nov 25, 2014 (0d) |
| Nov 25, 2014 | NEOT | ↑ Buy | 70,000 | $14.00 | $980K | Alta Partners VIII, LP | Nov 25, 2014 (0d) |
| Oct 21, 2014 | ESPR | ↑ Buy | 500,000 | $20.00 | $10.0M | Indirect | Oct 21, 2014 (0d) |
| Jul 29, 2014 | IMDZ | ↑ Buy | 299,559 | $12.00 | $3.6M | Direct | Jul 31, 2014 (2d) |
| Jun 23, 2014 | ZSPH | ↑ Buy | 200,000 | $18.00 | $3.6M | Indirect | Jun 25, 2014 (2d) |
| Jun 23, 2014 | ZSPH | ↑ Buy | 200,000 | $18.00 | $3.6M | Direct | Jun 25, 2014 (2d) |
| May 22, 2014 | AERI | ↓ Sell | 300,000 | $16.00 | $4.8M | Direct | May 27, 2014 (5d) |
| Apr 1, 2014 | AGTC | ↑ Buy | 155,645 | $12.00 | $1.9M | Indirect | Apr 1, 2014 (0d) |
| Feb 5, 2014 | TRVN | ↑ Buy | 472,410 | $7.00 | $3.3M | Indirect | Feb 7, 2014 (2d) |
| Oct 30, 2013 | AERI | ↑ Buy | 110,000 | $10.00 | $1.1M | Direct | Nov 1, 2013 (2d) |
| Sep 20, 2013 | ACRX | ↓ Sell | 158,153 | $10.59 | $1.7M | Acp IV, L.P. | Sep 23, 2013 (3d) |
| Sep 18, 2013 | ACRX | ↓ Sell | 128,780 | $10.42 | $1.3M | Acp IV, L.P. | Sep 18, 2013 (0d) |
| Jul 1, 2013 | ESPR | ↑ Buy | 235,714 | $14.00 | $3.3M | Indirect | Jul 1, 2013 (0d) |
| Apr 20, 2011 | ELLI | ↓ Sell | 322,998 | $6.00 | $1.9M | Direct | Apr 21, 2011 (1d) |
| Apr 20, 2011 | ELLI | ↓ Sell | 4,079 | $6.00 | $24K | Indirect | Apr 21, 2011 (1d) |
| Feb 16, 2011 | ACRX | ↑ Buy | 680,000 | $5.00 | $3.4M | Direct | Feb 18, 2011 (2d) |
| Feb 16, 2011 | ACRX | ↑ Buy | 680,000 | $5.00 | $3.4M | Indirect | Feb 18, 2011 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 372,999 | $0.09 | $34K | Direct | Jan 8, 2010 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 30,612 | $0.09 | $3K | By ACP III, LP | Jan 8, 2010 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 1,039 | $0.09 | $95 | By AEP III, LLC | Jan 8, 2010 (2d) |
| Sep 8, 2009 | TPTX | ↓ Sell | 717,837 | $0.22 | $161K | Indirect | Sep 8, 2009 (0d) |
| Oct 14, 2005 | CTRX | ↓ Sell | 166,937 | $13.00 | $2.2M | Indirect | Oct 18, 2005 (4d) |
| Oct 12, 2005 | CTRX | ↓ Sell | 247,314 | $13.00 | $3.2M | Indirect | Oct 14, 2005 (2d) |
| Aug 15, 2005 | CUTR | ↓ Sell | 1,737 | $23.33 | $41K | Direct | Aug 16, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BVS insiders
Open-market trades in the last 12 months
About Guy P Nohra's insider trades
Guy P Nohra is a director at Bioventus (BVS). Since Aug 15, 2005, Guy has reported 14 open-market purchases worth $49.0M and 21 sales worth $56.7M on SEC Form 4. In the last 12 months: 1 sale ($76K).
Their filings also include grants and awards (19 filings), conversions (17 filings), option exercises (14 filings), other transactions (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.